A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2
This study identifies a high-affinity nanobody that, when fused to other nanobodies, enhances their potency against SARS-CoV-2 by improving RBD binding without disrupting RBM conformation.